These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 15371346)
1. Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed. Lee RE; Li W; Chatterjee D; Lee RE Glycobiology; 2005 Feb; 15(2):139-51. PubMed ID: 15371346 [TBL] [Abstract][Full Text] [Related]
2. The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. Escuyer VE; Lety MA; Torrelles JB; Khoo KH; Tang JB; Rithner CD; Frehel C; McNeil MR; Brennan PJ; Chatterjee D J Biol Chem; 2001 Dec; 276(52):48854-62. PubMed ID: 11677227 [TBL] [Abstract][Full Text] [Related]
3. Methods for acquisition and assignment of multidimensional high-resolution magic angle spinning NMR of whole cell bacteria. Li W; Lee RE; Lee RE; Li J Anal Chem; 2005 Sep; 77(18):5785-92. PubMed ID: 16159107 [TBL] [Abstract][Full Text] [Related]
4. Sequencing of oligoarabinosyl units released from mycobacterial arabinogalactan by endogenous arabinanase: identification of distinctive and novel structural motifs. Lee A; Wu SW; Scherman MS; Torrelles JB; Chatterjee D; McNeil MR; Khoo KH Biochemistry; 2006 Dec; 45(51):15817-28. PubMed ID: 17176104 [TBL] [Abstract][Full Text] [Related]
5. Structural elucidation of the predominant motifs of the major cell wall arabinogalactan antigens from the borderline species Tsukamurella paurometabolum and Mycobacterium fallax. Tropis M; Lemassu A; Vincent V; Daffé M Glycobiology; 2005 Jul; 15(7):677-86. PubMed ID: 15761023 [TBL] [Abstract][Full Text] [Related]
6. Disruption of the SucT acyltransferase in Palčeková Z; Angala SK; Belardinelli JM; Eskandarian HA; Joe M; Brunton R; Rithner C; Jones V; Nigou J; Lowary TL; Gilleron M; McNeil M; Jackson M J Biol Chem; 2019 Jun; 294(26):10325-10335. PubMed ID: 31110045 [TBL] [Abstract][Full Text] [Related]
7. The carboxy terminus of EmbC from Mycobacterium smegmatis mediates chain length extension of the arabinan in lipoarabinomannan. Shi L; Berg S; Lee A; Spencer JS; Zhang J; Vissa V; McNeil MR; Khoo KH; Chatterjee D J Biol Chem; 2006 Jul; 281(28):19512-26. PubMed ID: 16687411 [TBL] [Abstract][Full Text] [Related]
8. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol. Khoo KH; Douglas E; Azadi P; Inamine JM; Besra GS; Mikusová K; Brennan PJ; Chatterjee D J Biol Chem; 1996 Nov; 271(45):28682-90. PubMed ID: 8910503 [TBL] [Abstract][Full Text] [Related]
9. The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. Zhang N; Torrelles JB; McNeil MR; Escuyer VE; Khoo KH; Brennan PJ; Chatterjee D Mol Microbiol; 2003 Oct; 50(1):69-76. PubMed ID: 14507364 [TBL] [Abstract][Full Text] [Related]
10. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy. Besra GS; Khoo KH; McNeil MR; Dell A; Morris HR; Brennan PJ Biochemistry; 1995 Apr; 34(13):4257-66. PubMed ID: 7703239 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans. Kaur D; Lowary TL; Vissa VD; Crick DC; Brennan PJ Microbiology (Reading); 2002 Oct; 148(Pt 10):3049-3057. PubMed ID: 12368438 [TBL] [Abstract][Full Text] [Related]
12. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Mikusová K; Slayden RA; Besra GS; Brennan PJ Antimicrob Agents Chemother; 1995 Nov; 39(11):2484-9. PubMed ID: 8585730 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of the docosanasaccharide arabinan domain of mycobacterial arabinogalactan and a proposed octadecasaccharide biosynthetic precursor. Joe M; Bai Y; Nacario RC; Lowary TL J Am Chem Soc; 2007 Aug; 129(32):9885-901. PubMed ID: 17655235 [TBL] [Abstract][Full Text] [Related]
14. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. Wolucka BA; McNeil MR; de Hoffmann E; Chojnacki T; Brennan PJ J Biol Chem; 1994 Sep; 269(37):23328-35. PubMed ID: 8083238 [TBL] [Abstract][Full Text] [Related]
15. Polysaccharide structural variability in mycobacteria: identification and characterization of phosphorylated mannan and arabinomannan. Maes E; Coddeville B; Kremer L; Guérardel Y Glycoconj J; 2007 Nov; 24(8):439-48. PubMed ID: 17510794 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of docosasaccharide arabinan motif of mycobacterial cell wall. Ishiwata A; Ito Y J Am Chem Soc; 2011 Feb; 133(7):2275-91. PubMed ID: 21287985 [TBL] [Abstract][Full Text] [Related]
17. The mycobacterial cell wall: biosynthesis of arabinogalactan and lipoarabinomannan. Besra GS; Brennan PJ Biochem Soc Trans; 1997 Aug; 25(3):845-50. PubMed ID: 9388559 [No Abstract] [Full Text] [Related]
18. Transfer of the first arabinofuranose residue to galactan is essential for Mycobacterium smegmatis viability. Shi L; Zhou R; Liu Z; Lowary TL; Seeberger PH; Stocker BL; Crick DC; Khoo KH; Chatterjee D J Bacteriol; 2008 Aug; 190(15):5248-55. PubMed ID: 18556798 [TBL] [Abstract][Full Text] [Related]
19. AftD, a novel essential arabinofuranosyltransferase from mycobacteria. Skovierová H; Larrouy-Maumus G; Zhang J; Kaur D; Barilone N; Korduláková J; Gilleron M; Guadagnini S; Belanová M; Prevost MC; Gicquel B; Puzo G; Chatterjee D; Brennan PJ; Nigou J; Jackson M Glycobiology; 2009 Nov; 19(11):1235-47. PubMed ID: 19654261 [TBL] [Abstract][Full Text] [Related]
20. A truncated lipoglycan from mycobacteria with altered immunological properties. Birch HL; Alderwick LJ; Appelmelk BJ; Maaskant J; Bhatt A; Singh A; Nigou J; Eggeling L; Geurtsen J; Besra GS Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2634-9. PubMed ID: 20133807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]